Stephen W Webster Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Stephen W Webster.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Stephen W Webster. Stephen W Webster is a SVP Finance & CFO in ADOLOR CORP ($ADLR) and a SVP, Finance & CFO in ADOLOR CORP ($ADLR) and a Chief Financial Officer in Spark Therapeutics, Inc. ($ONCE) and a Director in Viking Therapeutics, Inc. ($VKTX) and a Director in Nabriva Therapeutics plc ($NBRV) and a Director in NextCure, Inc. ($NXTC) and a Director in Nabriva Therapeutics Plc ($NBRV) and a Director in TCR2 THERAPEUTICS INC. ($TCRR).
Address: 700 PENNSYLVANIA DRIVE EXTON 19341 PA
Companies in which Stephen W Webster is an Insider
ADOLOR CORP
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Stephen W Webster: SVP, Finance & CFO, SVP Finance & CFO
Holdings: 0 shares
Latest Transaction: Dec 14 2011
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Nabriva Therapeutics Legacy plc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Stephen W Webster: Director
Holdings: 0 shares
Latest Transaction: Jun 27 2017
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Nabriva Therapeutics plc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Stephen W Webster: Director
Holdings: 25,500 shares
Current Value: $206,295
Latest Transaction: Jul 31 2020
$NBRV Market Capitalization: $180.88M
$NBRV Previous Close: $8.09
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
NextCure, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Stephen W Webster: Director
Holdings: 0 shares
Latest Transaction: Jun 15 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Spark Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Stephen W Webster: Chief Financial Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Dec 17 2019
$ONCE Market Capitalization: $2.00B
$ONCE Previous Close: $63.06
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
TCR2 THERAPEUTICS INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Stephen W Webster: Director
Holdings: 0 shares
Latest Transaction: Dec 11 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Viking Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Stephen W Webster: Director
Holdings: 8,000 shares
Current Value: $11,600
Latest Transaction: Jan 03 2020
$VKTX Market Capitalization: $31.36M
$VKTX Previous Close: $1.45
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Stephen W Webster
Sentiment: All, ADLR, NBRV, NBRV, NXTC, ONCE, TCRR, VKTX
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 11 2020 | TCRR | TCR2 THERAPEUTICS ... | Webster Stephen W | Director | Option Exercise | A | 31.83 | 12,100 | 385,143 | 12,100 | |
| Jul 31 2020 | NBRV | Nabriva Therapeuti ... | Webster Stephen W | Director | Option Exercise | A | 0.79 | 35,000 | 27,650 | 35,000 | |
| Jul 31 2020 | NBRV | Nabriva Therapeuti ... | Webster Stephen W | Director | Grant | A | 0.00 | 17,500 | 0 | 25,500 | 8 K to 25.5 K (+218.75 %) |
| Jun 15 2020 | NXTC | NextCure, Inc. | Webster Stephen W | Director | Option Exercise | A | 24.13 | 14,250 | 343,853 | 14,250 | |
| May 04 2020 | TCRR | TCR2 THERAPEUTICS ... | Webster Stephen W | Director | Option Exercise | A | 9.54 | 10,482 | 99,998 | 10,482 | |
| Jan 03 2020 | VKTX | Viking Therapeutic ... | Webster Stephen W | Director | Option Exercise | A | 7.95 | 22,000 | 174,900 | 22,000 | |
| Dec 17 2019 | ONCE | Spark Therapeutics ... | Webster Stephen W | CHIEF FINANCIAL OFF ... | Option Exercise | D | 0.00 | 19,500 | 0 | 0 |